Why Shares of Avadel Soared This Week
The company got its first FDA approval.
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Received tentative approval for LUMRYZâ„¢ (sodium oxybate) extended-release for oral suspension from FDA on July 18Advancing key activities to potentially...
Wall Street Analysts Think Avadel (AVDL) Could Surge 106%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 105.6% in Avadel (AVDL). While the effectiveness of this highly sought-after metric is questionable, the positive...
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming...
Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZâ„¢ (sodium oxybate) extended-release oral suspension
- Validates the safety profile and clinical efficacy of LUMRYZ - Pursuing strategies to accelerate final approval DUBLIN, Ireland, July 19, 2022 (GLOBE...